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【Abstract】Objective:    To assess the effects of
penehyclidine hydrochloride on patients with acute lung
injury (ALI), to observe the expression of Toll-like receptor
4 (TLR4) on the peripheral monocytes of ALI patients and
changes of inflammatory & anti-inflammatory cytokines and
to investigate the mechanism of TLR4 in ALI.
Methods:    Forty-five patients with ALI were randomly
divided into penehyclidine hydrochloride treatment group
(P group, n=21) and conventional treatment group (control
group, C group, n=24). Patients in both groups received
conventional treatment, including active treatment of the
primary disease, respiratory support, nutritional support and
fluid management therapy, while those in P group were given
penehyclidine hydrochloride (1 mg, im, q. 12 h) in addition.
The TLR4 expression of 20 healthy volunteers were detected.
The clinical effect, average length of stay in ICU and hospital,
values of PaO2 and PaO2/FiO2, expression of TLR4 on the
surface of peripheral blood mononuclear cells and some
serum cytokines were evaluated for 48 h.
Results:    The general conditions of the two groups
were improved gradually and PaO2 increased progressively.
Compared with 0 h, PaO2 and PaO2/FiO2 at 6, 12, 24 and 48 h
after treatment were significantly increased (P<0.05). The im-
provement in P group was obviously greater than that in C
group (P<0.05). The average length of hospitalization
showed no difference between the two groups, but
penehyclidine hydrochloride significantly decreased the av-
erage length of stay in ICU (t=3.485, P<0.01). The expression
of TLR4 in two groups were both obviously higher than
that of healthy volunteers (P<0.01). It decreased signifi-
cantly at 24 h (t=2.032, P<0.05) and 48 h (t=3.620, P<0.01)
and was lower in P group than in C group. The patients
who showed a higher level of TLR4 expression in early stage
had a worse prognosis and most of them developed acute
respiratory distress syndrome (ARDS). The incidence of
ARDS was 23.8% in P group and 29.17% in C group at 24 h.
Untill 48 h, there were other two patients developing ARDS
in control group. Serum IL-1, IL-8 and TNF-α expressions
reduced after 24 h in both groups. The reduction in P group
was more obvious than that in C group (P<0.05). IL-13 in-
creased gradually from 0 h to 24 h, and decreased slightly
at 48 h, which showed no difference between two groups
(t=1.028, P>0.05).
Conclusions:    Penehyclidine hydrochloride improves
the arterial oxygen pressure, down-regulates the expression
of TLR4 and restrains the inflammatory cytokines in the
downstream of TLR4 signaling pathway. It prevents the
development of ALI and can be considered as an important
drug in ALI treatment.
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Acute lung injury (ALI)/acute respiratory distresssyndrome (ARDS) is a severe clinical syndromecaused by many pulmonary and extrapul-
monary factors. The definition of this syndrome was
clarified in the American-European Consensus Confer-
ence in 1992.1 The term “acute lung injury” has been
used as an umbrella term for hypoxemic respiratory
failure, a severe version of which is ARDS. Pulmonary
alveoli epithelial cells and pulmonary capillary injury are
the main pathophysiologic characteristics, but the
pathogenesis is still unclear. At present, lots of re-
searches show that over-expression of cytokines and
their interactions are the root causes of ALI/ARDS.2
Regulating the expression of cytokines and blocking
the cascade of inflammatory medium are thus critical.
Recently, many studies find that the newly discovered
Toll-like receptor 4 (TLR4) can regulate the cytokine
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network in inflammatory response, which plays an im-
portant role in the process of ALI/ARDS. This study
evaluated the protective effect of penehyclidine
hydrochloride, a new type of receptor-selective anticho-
linergic medicine, on patients with ALI, investigated the
expression of TLR4 on peripheral monocytes and ex-
pression change of inflammatory & anti-inflammatory
cytokines, and explored the mechanism of TLR4 in the
pathogenesis of ALI.
METHODS
Patient enrollment
From September 2007 to August 2008, 547 patients
with a high risk of ALI were admitted in our hospital.
The following international diagnostic criteria of ALI were
used: (1) acute onset of sym ptom s, (2) PaO 2/FiO2≤
300 mm Hg, regardless of positive end-expiratory pres-
sure level, (3) bilateral infiltrations on frontal chest
radiograph, (4) pulmonary arterial wedge pressure≤
18 mm Hg or no clinical evidence of left atrial
hypertension. Patients who met any of the following
criteria were excluded from this trial: (1) diagnosed as
having ARDS (PaO2/FiO2≤200 mm Hg); (2) age>65
years or <16 years, (3) with a history of chronic lung
diseases or heart dysfunction, (4) liver and kidney func-
tions damaged in the past, (6) having contraindication
in using penehyclidine hydrochloride. After dynamic
monitoring of physiological indexes, chest imaging and
arterial blood gas analysis, a total of 45 patients were
involved in this randomized prospective clinical trial. This
research was approved by the Hospital Ethics Committee.
Grouping
First, we selected a starting number in the random
number table, and then selected a set of random num-
bers after the starting number. The order of hospitaliza-
tion of all patients was corresponded with the random
numbers. The odd array was taken as penehyclidine
hydrochloride group (P group), and the even array taken
as the control group (C group). Patients who died within
48 h in the two groups were excluded. Finally, there
were 21 patients, 16 males and 5 females with the mean
age of 42.33 years, in P group and 24 patients, 18 males
and 6 females with the mean age of 41.50 years, in C
group. The main causes were trauma in 21 cases, cere-
brovascular accidents in 8 cases, inhalation of vomitus
in 6 cases, severe infection in 5 cases, severe acute
pancreatitis in 3 cases, and ventilator-associated lung
injury in 2 cases. Analysis of variance showed no sig-
nificant difference in age, gender, heart rate (HR), dis-
tribution of causes and respiratory frequency at 0 h be-
tween the two groups (P>0.05).
Management
In C group, patients received the generally accepted
conventional treatment for ALI: active treatment of the
primary disease, respiratory support including oxygen
therapy, noninvasive ventilation and invasive ventilation,
nutritional support and fluid management therapy. Pa-
tients in P group received intramuscular injection of
penehyclidine hydrochloride (1 mg, 1/12 h) besides the
conventional treatment.
Parameters monitored
Acute physiological indexes, such as vital signs,
blood routine, blood biochemical parameters, arterial
blood gas analysis, electrocardiogram, inspired oxy-
gen concentration and changes of general conditions
were recorded within 48 h. For all patients, arterial blood
gas analysis and serological test were performed at
the 5 time points of 0, 6, 12, 24 and 48 h after ALI was
confirmed. The venous blood was injected into the anti-
coagulated tube and centrifugated for 15 minutes at 3000
r/min. Then the supernatant was preserved at -70°C to
determine cytokines, including tumor necrosis factor-
alpha (TNF-α), IL-1, IL-8 and IL-13 by double-antibody
sandwich enzyme-linked immunosorbent assay (ELISA,
Rapidbio Lab, USA) following the instructions strictly.
The expression of TLR4 on the surface of peripheral
blood mononuclear cells was detected by f low
cytometry (FCM) at 0, 24 and 48 h.  Anti-human TLR4
(10 µl, eBioscience Company, USA) phycoerythrin (PE)
was added into 100 µl anticoagulant blood. The mix-
ture was incubated for 30 minutes in the dark at room
temperature. And 10 µl mouse immunoglobulin G (IgG)-a-
PE (eBioscience Company, USA) was added into 100 µl
anticoagulant blood, acting as the control. Thereafter
hemolytic agents of 0.5 ml (BD Company, USA) was
added into the sample and stayed at room temperature
for 10 minutes. Then vortex oscillator was used and the
sample was centrifugated at a speed of 1500 r/min for
5 minutes. Then we washed it with phosphate buffered
saline (PBS, 0.01 mol/L, pH=7.4) twice. By using the
488 nm exciting light from the FACSCalibur flow cy-
tometer and setting an APC-CD14 positive gate, ne-
crotic cells and debris were removed. Cells in the gate
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ure 5). TLR4 expression of 20 healthy volunteers was
(0.41±0.27) mean fluotescence intensity (MFI). TLR4
detected at 0 h showed no significant difference be-
tween P group and C group (P>0.05), but both of them
differed significantly from that of healthy controls (P<0.01).
Compared with 0 h, TLR4 of two groups decreased at
24 and 48 h (P<0.05), and the decrease in P group was
greater than that in C group (t=2.032, P<0.05 at 24 h;
t=3.620, P<0.01 at 48 h, Figure 6).
Change of serum cytokines
Serum inflammatory & anti-inflammatory cytokines
showed no statistical difference between two groups at
0 h (P>0.05). Concentrations of TNF-α, IL-1, and IL-8
decreased gradually in both groups and there was a
significant difference between the two groups at 24 and
48 h (P<0.05). IL-13, one anti-inflammatory cytokine,
in two groups, increased from 0 to 24 h, and decreased
slightly at 48 h. At 24 h and 48 h it was significantly
different from that at 0 h (P<0.05), but there was no
statistical difference between the two groups at the
same time points (P>0.05) (Figure 7).
were CD14 monocytes. The fluorescence intensity of
the TLR4-PE located on the surface of monocytes was
detected.
Statistical analysis
Data were expressed as mean±standard deviation
(χ± s). We used SPSS (Version 17.0) to analyze all
the data. Student’s t test was used for measurement
data and χ2 test for count data and paired data. Fisher
exact probability test was used to compare all the rates
of two groups. Significance level was set at P<0.05.
RESULTS
General conditions and prognosis
Of all patients, HR, respiratory rate (RR) and acute
physiology and chronic health evaluation (APACHE) II
score were improved at 24 and 48 h, and there was no
significant difference between the two groups (P>0.05).
At 24 h, the incidence of ARDS in P group was 23.8 %
(5/21), while 29.17% (7/24) in C group. The other two
patients in C group developed ARDS between 24 h and
48 h. There was no newly-developed ARDS in P group
during this time period (Figure 1). In C group, the aver-
age length of stay in hospital and ICU was (16.79±4.63)
days and (5.54 ±1.29) days respectively, while in P group,
it was (15.33±3.87) days and (3.95±1.76) days
respectively. There was no significant difference in the
average length of stay in hospital between two groups,
but the data showed that penehyclidine hydrochloride
shortened the period of ICU stay significantly (t=3.458,
P<0.01, Figure 2).
Arterial blood gas analysis
At 0 h, patients presented with hypoxia, the oxy-
genation index PaO2/FiO2 was between 200-300 mm Hg
and there was no statistical difference between two
groups. Then PaO2 increased gradually and the increase
in P group was more obvious than that in C group at 6 h.
At 24 and 48 h, PaO2 was improved significantly, com-
pared with 0 h (P<0.05, Figure 3). PaO2/FiO2 showed
the same increase trend and it was improved more sig-
nificantly in P group than in C group at 6, 24 and 48 h
(P<0.05, Figure 4).
Detection of TLR4 expression on the surface of pe-
ripheral blood monocytes
Totally 1.0×104 monocytes were obtained accord-
ing to the CellQuest software (BD Company, USA, Fig-
Figure 2. The average length of hospitalization and ICU stay in
two groups. ##P<0.01, compared with C group.
Figure 1. The general conditions and incidence of ARDS in two
groups. **P<0.01, compared with 0 h.
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DISCUSSION
Nowadays ALI is usually regarded as a part of the
systemic inflammatory process, particularly injuries of
the chest and systemic sepsis. The lung and other tis-
sues show widespread destruction of the capillary
endothelium, extravasation of protein rich fluid and in-
terstitial edema. In addition, the alveolar basement
membrane is damaged and fluid seeps into the
airspaces, which stiffens the lung and causes ventila-
tion-perfusion mismatch.3-5
TLR, a novel family of receptors, has been demon-
strated to participate in the acute inflammatory process.4
Among the family members, TLR4 usually binds to li-
popolysaccharide (LPS), mycobacterial components,
cryptococcal capsule and lipoteichoic acid.7-10 It can ac-
tivate innate immunity and take part in the specific im-
mune response. TLR4 acts as an important connec-
tion between the innate and acquired immunity10 and
promotes the body to secrete a large number of
cathepsin, protease, TNF-α, IL-1, IL-6, IL-8 and other
inflammatory cytokines to promote the pathological pro-
cess of ALI/ARDS.
Effects of penehyclidine hydrochloride on patients
with ALI
Penehyclidine hydrochloride is a new type of anti-
cholinergic medicine which has both anti-muscarinic
and anti-nicotinic activities and it retains a potent cen-
tral and peripheral anti-cholinergic activ it ies.
Penehyclidine hydrochloride now has been widely used
in China as an antagonist of organophosphate poisoning.
It has the characteristics of M-cholinergic receptor sub-
type selectivity. Xiao and his colleagues11 found that
penehyclidine hydrochloride had little or no effect on
M2 subtypes receptors in isolated tracheal and lung
smooth muscles of guinea pig and could be used in
asthma and chronic obstructive pulmonary disease
management.12 When ALI/ARDS occurs, increase of
cholinergic receptors density and airway resistance,
hypertonia of vascular and airway smooth muscles, and
airway hyperresponsiveness will appear. Patients usu-
ally present with increased RR and airway secretions,
cyanosis, and restlessness in clinic. Shen et al13 found
that a high dose of penehyclidine hydrochloride could
significantly inhibit the increase of ALI pulmonary per-
meability using a LPS-induced ALI rat model. Electron
Figure 3. PaO2 in two groups. **P<0.01, compared with 0 h;
##P<0.01, compared with the C group. Figure 4. The oxygenation
index in two groups. *P<0.05 and **P<0.01 compared with 0 h;
#P<0.05 and ##P<0.01, compared with C group.
Figure 6. Expression of TLR4 on peripheral blood monocytes in
two groups. *P<0.05 and **P<0.01, compared with 0 h; #P<0.05,
##P<0.01 compared with C group.
Figure 7. Detection of cytokines in two groups. *P<0.05 and **P<0.01,
compared with 0 h; #P<0.05 and ##P<0.01, compared with C group.
Figure 5. Peripheral blood monocytes obtained. According to the
CellQuest software, they count 1.0 ×104.
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microscopy showed that damage of pulmonary mi-
crovascular endothelial cells and basement mem-
brane were reduced obviously compared with the con-
trol group. Thus they speculated that penehyclidine hy-
drochloride could inhibit the increase of lung perme-
ability by reducing injury of the microvascular barrier in
rats. In recent years, more and more researches14-16
found that penehyclidine hydrochloride can be used to
treat ALI because it can improve the microcirculation,
reduce the permeability of capillary, exert a cell protec-
tive effect and reduce the lysosome release.
Our study observed that the HR, RR, and APACHE II
score of patients in the two groups were improved after
treatment for 48 h. PaO2 and oxygenation index of both
groups increased gradually from 0 h, and the increase
was greater in P group than in C group at 6 h. This
suggests that the application of penehyclidine hydro-
chloride can improve the anoxia and respiratory func-
tion in patients with ALI at an early stage. The HR and
RR decreased gradually, and there was no significant
difference between the two groups, suggesting that
penehyclidine hydrochloride does not increase the HR
in ALI patients.
Traditional cholinergic receptor antagonists would
increase HR, and thus increase the myocardial oxy-
gen consumption, which limits their application in the
treatment of ALI. Penehyclidine hydrochloride, which
does not have this side effect, is expected to be a po-
tential choice for ALI management. In this study totally
14 patients developed ARDS and the incidence was
higher in C group than in P group at 24 and 48 h but
there was no statistical difference between the two
groups. This may be due to the small size of sample.
In the end, 4 patients in C group died and only one in P
group died. The main causes of death were severe hy-
poxemia and multiple organ failure.
Changes of serum anti-inflammatory & inflamma-
tory cytokines and TLR4 expression on the periph-
eral blood mononuclear cells in ALI patients after
treatment
TLR4 was found by Janewary and Medzzhitor6 in
1997. It is a type-I transmembrane protein and mainly
expressed in the placenta and lung tissues. After bind-
ing with exogenous and/or endogenous ligand, TLR4
activated NF-κB-induced inflammatory cytokine se-
cretions through a series of signal transduction
pathways.17 We found that TLR4 expression in periph-
eral blood mononuclear cells was much lower in healthy
people than in ALI patients (P<0.01). In this trial, the
TLR4 expression in two groups declined after treatment,
and the decrease in P group was greater than that in C
group at 24 h and 48 h. This showed that penehyclidine
hydrochloride intervention reduced TLR4 expression in
the peripheral blood of ALI patients, but whether it en-
hanced the negative regulation of the body or there ex-
isted other mechanisms needs to be confirmed by fur-
ther studies.
Our trial found that the concentrations of inflamma-
tory cytokines including TNF-α, IL-1 and IL-8 de-
creased after 0 h in two groups. The highest values of
inflammatory cytokines were detected at 0 h. Because
the second time point was set at 6 h, the peak of in-
flammatory cytokines would be between 0 h and 6 h. De-
cline of TLR4 expression and inflammatory cytokines
was consistent with the changes of clinical mani-
festations, which proves that the inflammatory response
is the core of ALI. This provides a more solid clinical
evidence for the theory of excessive inflammatory
response. Penehyclidine hydrochloride inhibited the
expression of TLR4 and inflammatory cytokines in the
downstream of TLR4 signaling pathway, but the expres-
sion of anti-inflammatory cytokines did not show differ-
ences between the two groups. Thus we can infer that
penehyclidine hydrochloride inhibit the expression of
inflammatory cytokines by down-regulating TLR4 but
not by increasing anti-inflammatory IL-13.
Mechanisms of TLR4 in the pathogenesis of ALI
The relationship between TLR4, an endotoxin
receptor, and LPS-induced ALI has been explored by
several studies. Togbe and his colleagues18 found that
TNF-α expression, microvascular and alveolar epithe-
lial injury, respiratory protein leakage, lung micro-struc-
tural damage and TLR4 gene dosage were positively
correlated through an animal experiment of LPS-induced
ALI on rats. It is reported that the degree of inflamma-
tory response depends on the level of TLR4 expression.
Our finding is in accordance with this view: TLR4 ex-
pression declined gradually with the improvement of ALI.
We also found that patients who showed high expres-
sion of TLR4 at early stage (0 h) had poor prognosis.
Among them, ALI progressed rapidly; the typical clini-
cal manifestation of ARDS and hyaline membrane for-
mation could be observed by bronchoscopy. Five pa-
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tients with TLR4 higher than 20.8 MFI at 0 h all devel-
oped ARDS within 48 h and finally 4 died. Many foreign
scholars have reported that TLR4 is closely related with
various diseases19-21 because it has lots of ligands, which
are mainly related to inflammatory responses mediated
by TLR4. TLR4 can recognize not only the Gram-nega-
tive bacteria lipopolysaccharide but also the mycobac-
terium tuberculosis, aspergil lus, cryptococcus
neoformans, candida albicans and other pathogenic mi-
cro-organisms with molecular patterns, as well as en-
dogenous molecules.22
Apart from this, when severe non-infectious pulmo-
nary inflammation happens, though without infection or
invasion of pathogenic bacteria, abundant endogenous
ligands could still trigger TLR4, activate macrophages
and release large number of inflammatory mediators,
thus bring the body into a state of excessive inflamma-
tory response.
At present, mechanical ventilation is still the main
clinical treatment of ALI/ARDS23,24 and the medication
is disappointing. Some drugs that were once reported
to have a potential protective effect on ALI, such as
glucocorticoid, pulmonary surfactant, NO, prostaglan-
din E1, cytokine antagonists, monoclonal antibodies,
etc, are not recommended now.25 In this study, we used
penehyclidine hydrochloride, a new type of receptor-
selective cholinergic receptor antagonist, to treat ALI
and achieved a good clinical effect. We found that
penehyclidine hydrochloride could increase the vascu-
lar smooth muscle spasm, inhibit respiratory gland se-
cretion and improve oxygenation at an early stage, in-
hibit the expressions of TLR4 and inflammatory
cytokines in the downstream of TLR4 signaling path-
way significantly, and have a protective effect on pa-
tients with ALI.
TLR4 is only a member of the Toll-like receptor family,
so we cannot preclude that other TLRs may play an
uncertain role in the process of ALI. Maybe there exists
coordination or antagonism among those TLRs in the
ALI pathogenesis, but their specific distribution in the
lung and the variety of ligands make TLR4 play an indis-
pensable role in this process. We recommend TLR4 as
a marker to determine the prognosis of ALI.
Conclusion
Penehyclidine hydrochloride can improve the arte-
rial oxygen pressure, down-regulate TLR4 expression
and restrain inflammatory cytokines in the downstream
of TLR4 signaling pathway. This inhibitory action is ac-
complished by down-regulating TLR4, but not by height-
ening the ant i-inf lammatory factor of  IL-13.
Penehyclidine hydrochloride can prevent the develop-
ment of ALI, so we suggest that it be considered as an
important medicine in ALI treatment. TLR4 plays a sig-
nificant role in the pathogenesis of ALI, and it is recom-
mended that TLR4 expression be a prognostic sign.
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